FI112218B - Menetelmä optisesti puhtaan tai rikastetun piperatsiini-2-tert-butyylikarboksiamidisubstraatin valmistamiseksi - Google Patents

Menetelmä optisesti puhtaan tai rikastetun piperatsiini-2-tert-butyylikarboksiamidisubstraatin valmistamiseksi Download PDF

Info

Publication number
FI112218B
FI112218B FI963054A FI963054A FI112218B FI 112218 B FI112218 B FI 112218B FI 963054 A FI963054 A FI 963054A FI 963054 A FI963054 A FI 963054A FI 112218 B FI112218 B FI 112218B
Authority
FI
Finland
Prior art keywords
tert
group
process according
piperazine
butylcarboxamide
Prior art date
Application number
FI963054A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963054A (fi
FI963054A0 (fi
Inventor
David Askin
Kai Rossen
Paul Reider
Richard Varsolona
Ralph Volante
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI963054A publication Critical patent/FI963054A/fi
Publication of FI963054A0 publication Critical patent/FI963054A0/fi
Application granted granted Critical
Publication of FI112218B publication Critical patent/FI112218B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
FI963054A 1994-02-04 1996-08-01 Menetelmä optisesti puhtaan tai rikastetun piperatsiini-2-tert-butyylikarboksiamidisubstraatin valmistamiseksi FI112218B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19291694A 1994-02-04 1994-02-04
US19291694 1994-02-04
PCT/US1995/001232 WO1995021162A1 (en) 1994-02-04 1995-01-30 Process for making hiv protease inhibitors
US9501232 1995-01-30

Publications (3)

Publication Number Publication Date
FI963054A FI963054A (fi) 1996-08-01
FI963054A0 FI963054A0 (fi) 1996-08-01
FI112218B true FI112218B (fi) 2003-11-14

Family

ID=22711555

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963054A FI112218B (fi) 1994-02-04 1996-08-01 Menetelmä optisesti puhtaan tai rikastetun piperatsiini-2-tert-butyylikarboksiamidisubstraatin valmistamiseksi

Country Status (20)

Country Link
US (1) US5663341A (ja)
EP (1) EP0741712B1 (ja)
JP (1) JPH09508628A (ja)
KR (1) KR100337579B1 (ja)
AT (1) ATE206407T1 (ja)
AU (1) AU691878B2 (ja)
BR (1) BR9506727A (ja)
CA (1) CA2180947A1 (ja)
CZ (1) CZ291774B6 (ja)
DE (1) DE69523038T2 (ja)
ES (1) ES2161863T3 (ja)
FI (1) FI112218B (ja)
HU (1) HUT76303A (ja)
NZ (1) NZ279734A (ja)
RO (1) RO118292B1 (ja)
RU (1) RU2135482C1 (ja)
SK (1) SK281861B6 (ja)
TW (1) TW472047B (ja)
UA (1) UA46730C2 (ja)
WO (1) WO1995021162A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110255A (en) * 1993-07-16 1998-12-06 Merck & Co Inc Creation and resolution of 2 tert-butylcarboxamidopiprazine
US5464788A (en) * 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
DE69527683T2 (de) * 1994-04-22 2003-04-10 Koei Chemical Co Verfahren zur herstellung von optisch aktivem n-tert-butyl-2-piperazincarboxamidamid
ES2116029T3 (es) * 1994-11-04 1998-07-01 Yamakawa Chemical Ind Procedimiento para preparar derivados de piperazina opticamente activos e intermedios para prepararlos.
AU4538296A (en) * 1995-01-23 1996-08-14 Lonza A.G. Process for the production of 1,4,5,6-tetrahydropyrazine-2-carboxylic acid amides
US5618937A (en) * 1995-03-15 1997-04-08 Merck & Co., Inc. Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide
US5612484A (en) * 1995-05-18 1997-03-18 Merck & Co., Inc. Process for making HIV protease inhibitors
DE19536658C2 (de) * 1995-09-30 1998-02-19 Degussa Verfahren zur kontinuierlichen Herstellung von basischen, cyclischen, optisch aktiven alpha-Aminosäuren
CA2201218C (en) * 1996-04-23 2004-09-28 Rudolf Fuchs Process for the preparation of optically active piperazine-2-carboxylic acid derivatives
EP1592389B1 (en) 2003-02-14 2009-04-22 Laboratoires Serono SA Piperazine-2-carboxamide derivatives
GB0314260D0 (en) * 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB604185A (en) * 1940-08-08 1948-06-30 Arthur Mandl Improvements in electric rectifier systems used in power or control systems such as for follow-up systems
US3692775A (en) * 1969-03-17 1972-09-19 Allied Chem Racemization of d-or l-{60 -amino-caprolactam in the presence of metal ions
US3852351A (en) * 1972-10-02 1974-12-03 Fmc Corp Chlorination of acetoacetamides
JPH01117869A (ja) * 1987-10-30 1989-05-10 Hokuriku Seiyaku Co Ltd ２−アミノメチルピペラジン誘導体
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
ATE163926T1 (de) * 1991-11-08 1998-03-15 Merck & Co Inc Hiv-protease-inhibitoren verwendbar in der aids- behandlung
MX9308016A (es) * 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.

Also Published As

Publication number Publication date
KR100337579B1 (ko) 2002-11-13
MX9603218A (es) 1997-07-31
RU2135482C1 (ru) 1999-08-27
DE69523038D1 (de) 2001-11-08
CZ227296A3 (en) 1997-01-15
EP0741712B1 (en) 2001-10-04
FI963054A (fi) 1996-08-01
FI963054A0 (fi) 1996-08-01
AU1696795A (en) 1995-08-21
ES2161863T3 (es) 2001-12-16
EP0741712A1 (en) 1996-11-13
TW472047B (en) 2002-01-11
CA2180947A1 (en) 1995-08-10
RO118292B1 (ro) 2003-04-30
HU9602143D0 (en) 1996-09-30
WO1995021162A1 (en) 1995-08-10
HUT76303A (en) 1997-07-28
UA46730C2 (uk) 2002-06-17
NZ279734A (en) 1998-05-27
AU691878B2 (en) 1998-05-28
CZ291774B6 (cs) 2003-05-14
SK281861B6 (sk) 2001-08-06
BR9506727A (pt) 1997-09-23
SK100696A3 (en) 1997-03-05
US5663341A (en) 1997-09-02
ATE206407T1 (de) 2001-10-15
DE69523038T2 (de) 2002-06-06
JPH09508628A (ja) 1997-09-02

Similar Documents

Publication Publication Date Title
FI112218B (fi) Menetelmä optisesti puhtaan tai rikastetun piperatsiini-2-tert-butyylikarboksiamidisubstraatin valmistamiseksi
US20200331883A1 (en) Enantiomeric separation of racemic nicotine by addition of an o,o'-disubstituted tartaric acid enantiomer
AU676079B2 (en) Process for making HIV protease inhibitors
US5420353A (en) Regiospecific process to make cis-1-amino-2-alkanol from epoxide
AU679770B2 (en) Process for making HIV protease inhibitors
SK115396A3 (en) Regiospecific processes to make cis-1-amino-2-alkanols
US5723615A (en) Process for preparing 4-tert-butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamide
MXPA96003218A (en) Procedure for making inhibitors of human immunodeficiency and composite intermediate virus proteas
US5508404A (en) Reductive amination process
GB2333775A (en) Process for preparing 4-alkylcarbonyl-(s)-piperazine-2-alkylcarboxamide